Published 1 year ago

J&J tops 4Q earnings forecasts as profit, revenue slip

Summary by Ground News

The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast. Company sales were hurt last year by the strong U.S. dollar, which is currently worth more than a euro. J&J brings in nearly half of its sales from outside the United States. The company also booked costs in the fourth quarter for winding down production of the vaccine.

0 Articles

All

Left

Center

Right

Associated Press News

J&J tops 4Q earnings forecasts as profit, revenue slip

1 year ago·United States

Read Full Article

KIFI

J&J tops 4Q earnings forecasts as profit, revenue slip

By TOM MURPHY AP Health Writer Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue. The health care giant said Tuesday that fourth-quarter earnings slipped 26% to $3.52 billion and revenue declined 4% to $23.7 billion. Adjusted earnings totaled $2.35 per share. Analysts expected earnings of $2.23 per share on $23.9 billion in revenue, according to FactS…

1 year ago·Idaho Falls, United States

Read Full Article

The Epoch Times

J&J Tops 4th-Quarter Earnings Forecasts as Profit, Revenue Slip

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue. The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast. J&J said fourth-quarter earnings slipped 26 percent to $3.52 billion and revenue declined 4.4 percent to $23.71 billion. Company sales were hurt last year by the strong U.S. dollar, which is currently worth mo…

1 year ago·New York, United States

Read Full Article

Bloomberg

J&J CFO on Earnings Forecast, Costs and Consumer Spinoff

Johnson & Johnson CFO Joseph Wolk discusses the company's stronger-than-expected earnings forecast for 2023 and cost pressures with Guy Johnson and Alix Steel on "Bloomberg Markets." (Source: Bloomberg)

1 year ago·United States

Read Full Article

MY Northwest

J&J tops 4Q earnings forecasts as profit, revenue slip

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue. The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast. Its shares started climbing in early morning trading. J&J said fourth-quarter earnings slipped 26% to $3.52 billion and revenue declined 4.4% to $23.71 billion. Company sales were hurt last year by the stron…

1 year ago·Tacoma, United States

Read Full Article

Boston Herald

J&J tops 4Q earnings forecasts as profit, revenue slip

By TOM MURPHY Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue. The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast. J&J said fourth-quarter earnings slipped 26% to $3.52 billion and revenue declined 4.4% to $23.71 billion. Company sales were hurt last year by the strong U.S. dollar, which is currently worth mo…

1 year ago·Boston, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.